Immortalization and malignant transformation of Eukaryotic cells
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The process of cellular transformation has been amply studied in vitro using immortalized cell lines. Immortalized cells never have the normal diploid karyotype, nevertheless, they cannot grow over one another in cell culture (contact inhibition), do not form colonies in soft agar (anchorage-dependent growth) and do not form tumors when injected into immunodeficient rodents. All these characteristics can be obtained with additional chromosome changes. Multiple genetic rearrangements, including whole chromosome and gene copy number gains and losses, chromosome translocations, gene mutations are necessary for establishing the malignant cell phenotype. Most of the experiments detecting transforming ability of genes overexpressed and/or mutated in tumors (oncogenes) were performed using mouse embryonic fibroblasts (MEFs), NIH3T3 mouse fibroblast cell line, human embryonic kidney 293 cell line (HEK293), and human mammary epithelial cell lines (mainly HMECs and MC-F10A). These cell lines have abnormal karyotypes and are prone to progress to malignantly transformed cells. This review is aimed at understanding the mechanisms of cell immortalization by different "immortalizing agents", oncogene-induced cell transformation of immortalized cells and moderate response of the advanced tumors to anticancer therapy in the light of tumor "oncogene and chromosome addiction", intra-/intertumor heterogeneity, and chromosome instability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumour evolution inferred by single-cell sequencing
Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., et al. (2011) · Nature · doi:10.1038/nature09807 · Cited by 2,598
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
RAS oncogenes: the first 30 years
Malumbres, M., & Barbacid, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1097 · Cited by 1,902 · cited 1×
“In early 80th it was shown that immortalized NIH3T3 mouse fibroblast cells introduced with total genomic DNA from human tumors were converted into cancer cells; later it was found that H RAS gene harboring a point mutation induced transformation of NIH3T3 cells in culture and conferred on them the ability to induce tu…”
BackgroundA comprehensive catalogue of somatic mutations from a human cancer genome
Pleasance, E. D., Cheetham, R. K., Stephens, P. J., McBride, D. J., Humphray, S. J., Greenman, C. D., Varela, I., Lin, M.-L., Ordóñez, G. R., Bignell, G. R., et al. (2010) · Nature · doi:10.1038/nature08658 · Cited by 1,696 · cited 1×
“Results of sequencing COLO 829 cancer cell line derived, before treatment, from a metastasis of a malignant melanoma demon strated a total of 292 somatic base substitutions in pro tein coding sequences [404].”
BackgroundTumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
Campbell, P. J., Yachida, S., Mudie, L. J., Stephens, P. J., Pleasance, E. D., Stebbings, L. A., Morsberger, L. A., Latimer, C., McLaren, S., Lin, M.-L., et al. (2010) · Nature · doi:10.1038/nature09460 · Cited by 1,317
Dang, C. V., O’Donnell, K. A., Zeller, K. I., Nguyen, T., Osthus, R. C., & Li, F. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.014 · Cited by 1,188 · cited 1×
“Activation of ERK markedly enhances c MYC protein stability, which can transcriptionally upregu late expression of certain cycline dependent kinases (CDK4) and cyclins (A, B1, D1, D2 and E), and represses cyclin dependent kinase inhibitors (p15INK4B, p21CIP1 and p27KIP1) [48, 101, 102, 272].”
BackgroundDickson, M. A., Hahn, W. C., Ino, Y., Ronfard, V., Wu, J. Y., Weinberg, R. A., Louis, D. N., Li, F. P., & Rheinwald, J. G. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1436-1447.2000 · Cited by 1,104
Meloche, S., & Pouysségur, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210414 · Cited by 1,091 · cited 7×
“The rate limiting step in the pyrimidine pathway is catalysed by the carbamoyl phosphate synthetase enzyme, which is part of the large multifunctional protein CAD [268, 270].”
BackgroundInfluentialBoveri revisited: chromosomal instability, aneuploidy and tumorigenesis
Holland, A. J., & Cleveland, D. W. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2718 · Cited by 859
Chromosome aberrations in solid tumors
Albertson, D. G., Collins, C., McCormick, F., & Gray, J. W. (2003) · Nature Genetics · doi:10.1038/ng1215 · Cited by 812
Sherr, C. J., & DePinho, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)00046-5 · Cited by 745
Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants
Greulich, H., Chen, T.-H., Feng, W., Jänne, P. A., Alvarez, J. V., Zappaterra, M., Bulmer, S. E., Frank, D. A., Hahn, W. C., Sellers, W. R., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020313 · Cited by 677 · cited 1×
“EGER mutant [236] PAR [257]”
Chapter 2 PI3K/PTEN Signaling in Angiogenesis and Tumorigenesis
(2009) · Advances in Cancer Research · doi:10.1016/s0065-230x(09)02002-8 · Cited by 620 · cited 1×
“Nevertheless, RAS dependent extracellular signal regulated kinase 1/2 (ERK1/2) mitogen activated protein (MAP) kinase [268–270] and phosphoinositide 3 ki nase (PI3K) mammalian target of rapamycin (mTOR) AKT cascades [271] are the key signal transduction path ways responsible for integrating the different environ menta…”
BackgroundAneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast
Pavelka, N., Rancati, G., Zhu, J., Bradford, W. D., Saraf, A., Florens, L., Sanderson, B. W., Hattem, G. L., & Li, R. (2010) · Nature · doi:10.1038/nature09529 · Cited by 577 · cited 1×
“Inter estingly, levels of protein expression in aneuploid yeast strains largely scale with chromosome copy numbers, following the same trend as that observed for the tran scriptome [333].”
BackgroundHernando, E., Nahlé, Z., Juan, G., Diaz-Rodriguez, E., Alaminos, M., Hemann, M., Michel, L., Mittal, V., Gerald, W., Benezra, R., et al. (2004) · Nature · doi:10.1038/nature02820 · Cited by 562
Aberrant Overexpression of Satellite Repeats in Pancreatic and Other Epithelial Cancers
Ting, D. T., Lipson, D., Paul, S., Brannigan, B. W., Akhavanfard, S., Coffman, E. J., Contino, G., Deshpande, V., Iafrate, A. J., Letovsky, S., et al. (2011) · Science · doi:10.1126/science.1200801 · Cited by 540
Romagosa, C., Simonetti, S., López-Vicente, L., Mazo, A., Lleonart, M. E., Castellvi, J., & Ramon y Cajal, S. (2011) · Oncogene · doi:10.1038/onc.2010.614 · Cited by 509
Proliferation of aneuploid human cells is limited by a p53-dependent mechanism
Thompson, S. L., & Compton, D. A. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200905057 · Cited by 494 · cited 2×
“one of many proteins involved in ensuring chromo some segregation fidelity is disrupted by the missegre gation of the chromosome carrying that gene, the resulting imbalance can further compromise chromo some segregation accuracy [176].”
BackgroundMany roads lead to oncogene-induced senescence
Courtois-Cox, S., Jones, S. L., & Cichowski, K. (2008) · Oncogene · doi:10.1038/sj.onc.1210950 · Cited by 397 · cited 5×
“Cellular senescence in vivo is now recognized to play an active role as a tumor suppressor pathway [36, 37], in the loss of regenerative potential in aging tissues and in the pathogenesis of cardiovascular dis eases [38].”
BackgroundInfluentialCritical pathways in cellular senescence and immortalization revealed by gene expression profiling
Fridman, A. L., & Tainsky, M. A. (2008) · Oncogene · doi:10.1038/onc.2008.213 · Cited by 385 · cited 6×
“These cellular factors cooperate to initiate senescence, thereby pre venting cellular proliferation in the presence of dam aged chromosomes and hence limiting the acquisition of potential pathogenic mutations [33, 41].”
BackgroundInfluentialDefining the transcriptome and proteome in three functionally different human cell lines
Lundberg, E., Fagerberg, L., Klevebring, D., Matic, I., Geiger, T., Cox, J., Älgenäs, C., Lundeberg, J., Mann, M., & Uhlen, M. (2010) · Molecular Systems Biology · doi:10.1038/msb.2010.106 · Cited by 373
The ATM–p53 pathway suppresses aneuploidy-induced tumorigenesis
Li, M., Fang, X., Baker, D. J., Guo, L., Gao, X., Wei, Z., Han, S., van Deursen, J. M., & Zhang, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005960107 · Cited by 257
Stress-induced senescence in human and rodent astrocytes
Bitto, A., Sell, C., Crowe, E., Lorenzini, A., Malaguti, M., Hrelia, S., & Torres, C. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.06.021 · Cited by 204
Genetic and Epigenetic Changes in Human Epithelial Cells Immortalized by Telomerase
Farwell, D. G., Shera, K. A., Koop, J. I., Bonnet, G. A., Matthews, C. P., Reuther, G. W., Coltrera, M. D., McDougall, J. K., & Klingelhutz, A. J. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65025-0 · Cited by 196 · cited 2×
“Human adenoid epithelial cells and foreskin keratinocytes [81] Human epidermal keratinocytes [156]”
BackgroundA non-genetic route to aneuploidy in human cancers
Krajcovic, M., Johnson, N. B., Sun, Q., Normand, G., Hoover, N., Yao, E., Richardson, A. L., King, R. W., Cibas, E. S., Schnitt, S. J., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2174 · Cited by 188
Transformation of normal human cells in the absence of telomerase activation
Seger, Y. R., Garcı́a-Cao, M., Piccinin, S., Cunsolo, C. L., Doglioni, C., Blasco, M. A., Hannon, G. J., & Maestro, R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00183-6 · Cited by 159
Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130
Dannenberg, J.-H., Schuijff, L., Dekker, M., van der Valk, M., & Riele, H. T. (2004) · Genes & Development · doi:10.1101/gad.322004 · Cited by 137
RB acute loss induces centrosome amplification and aneuploidy in murine primary fibroblasts
Iovino, F., Lentini, L., Amato, A., & Di Leonardo, A. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-38 · Cited by 94 · cited 2×
“Acute pRB sup pression in IMR90 cells [184], HCT116 cells [185], primary human fibroblasts [186], mouse embryonic fibroblasts [180], and mouse adult fibroblasts [187] caused misregulation of chechpoint genes [180, 185, 186] and, as a consequence, gave rise to centrosome amplification, multipolar spindles, anaphase bri…”
Intratumoral Patterns of Genomic Imbalance in Glioblastomas
Nobusawa, S., Lachuer, J., Wierinckx, A., Kim, Y. H., Huang, J., Legras, C., Kleihues, P., & Ohgaki, H. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00395.x · Cited by 75
The Retinoblastoma Gene Family in Cell Cycle Regulation and Suppression of Tumorigenesis
Dannenberg, J.-H., & te Riele, H. P. J. (2006) · Results and Problems in Cell Differentiation · doi:10.1007/400_002 · Cited by 47
RB loss promotes aberrant ploidy by deregulating levels and activity of DNA replication factors
Srinivasan, S. V., Mayhew, C. N., Schwemberger, S., Zagorski, W., & Knudsen, E. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700542200 · Cited by 42
HCCRBP‐1 directly interacting with HCCR‐1 induces tumorigenesis through P53 stabilization
Ha, S., Shin, S. M., Lee, Y. J., Kim, S., Kim, H. K., Namkoong, H., Lee, H., Lee, Y. S., Cho, Y., Park, Y. G., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23146 · Cited by 10
Cited by
Stepanenko, A. A., & Dmitrenko, V. V. (2015) · Gene · doi:10.1016/j.gene.2015.05.065 · Cited by 325
Self-citationTransient and stable vector transfection: Pitfalls, off-target effects, artifacts
Stepanenko, A. A., & Heng, H. H. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2017.05.002 · Cited by 109
Self-citationPractical Use of Immortalized Cells in Medicine: Current Advances and Future Perspectives
Voloshin, N., Tyurin-Kuzmin, P., Karagyaur, M., Akopyan, Z., & Kulebyakin, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612716 · Cited by 77
“Immortalized cell lines are cell lines in which the Hayflick limit has been overcome with the help of genetic modifications, and as a result, a theoretically infinite number of divisions is possible [7].”
BackgroundNHEJ pathway is involved in post-integrational DNA repair due to Ku70 binding to HIV-1 integrase
Knyazhanskaya, E., Anisenko, A., Shadrina, O., Kalinina, A., Zatsepin, T., Zalevsky, A., Mazurov, D., & Gottikh, M. (2019) · Retrovirology · doi:10.1186/s12977-019-0492-z · Cited by 46
Trusting the forces of our cell lines
Moro-López, M., Farré, R., Otero, J., & Sunyer, R. (2024) · Cells & Development · doi:10.1016/j.cdev.2024.203931 · Cited by 2
Metadata
- Authors
- Stepanenko, A. A., & Kavsan, V. M.
- Venue
- Cytology and Genetics
- Publisher
- Allerton Press
- Published
- 2012-04
- Volume
- 46
- Issue
- 2
- Pages
- 96-129
- ISSN
- 0095-4527 (ISSN-L)
- 1934-9440
- OpenAlex
- W1989997581
- Cited by
- 51
- References
- 33
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.